Clinical aspects of C3dg and C5b-9 in human membranous nephropathy.
Coupes
B
B
Department of Renal Medicine, Manchester Royal Infirmary, UK.
Brenchley
P E
PE
Short
C D
CD
Mallick
N P
NP
D000328:Adult; D003167:Complement Activation; D003179:Complement C3b / Q000378:metabolism* / Q000652:urine; D015938:Complement Membrane Attack Complex / Q000378:metabolism* / Q000652:urine; D005260:Female; D005922:Glomerulonephritis, IGA / Q000276:immunology; D015433:Glomerulonephritis, Membranous / Q000276:immunology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010446:Peptide Fragments / Q000378:metabolism* / Q000652:urine
D015938:Complement Membrane Attack Complex; D010446:Peptide Fragments; C045477:complement C3d,g; D003179:Complement C3b